Fox Business - The Power to Prosper
Search Site

Wednesday, April 7, 2010 as of 11:14 AM ET

Watson Pharmaceuticals

Watson Pharmaceuticals, Incorporated (NYSE: [http://www.nyse.com/about/listed/lcddata.html?ticker=WPI WPI])is a leading, integrated global pharmaceutical company.

Read More at Wikipedia ›

Related Topics

  1. Pharmaceuticals
  2. Ranbaxy Laboratories
  3. Vertex Pharmaceuticals
  4. Amylin Pharmaceuticals
  5. Regeneron Pharmaceuticals
  6. IMS Health
Get updates on Watson Pharmaceuticals
US HOT STOCK FUTURES: HOT STOCKS TO WATCH

Among the companies with shares expected to actively trade in Friday's session are Delphi Automotive PLC (DLPH), VeriFone Systems Inc.

(PAY) and SemTech Corp. (SMTC).Delphi made a binding offer to acquire FCI Group's motorized vehicles division in a deal valued at EUR765 million, or $972 million, that will strengthen the parts maker's connector product portfolio. The deal is expected to be accretive to the company's 2013 earnings. Shares jumped 12% to $30.91 after hours.VeriFone's fiscal second-quarter earnings fell 43% as restructuring and acquisition-related costs continued to overshadow stronger revenue and better-than-expected core profit. Shares sank 9.4% to $40.77 after hours as guidance estimates were mostly below Wall Street expectations.Semtech's first-quarter earnings slid 90% as expenses and a purchase accounting adjustment related to the chip maker's acquisition of Gennum Corp. weighed on margins and bottom-line results. Shares slipped 4% to $22.75 after hours as adjusted e...

Read More ›

  1. Deutsche Bank Takes EUR257 Million Hit On Actavis-Watson Deal

    Deutsche Bank AG (DB, DBK.XE) said Wednesday it will book a EUR257 million impairment charge in the first quarter from exiting its exposure to generic drug maker Act...

  2. Watson, Actavis To Unveil Deal On Wednesday: Sources - Reuters

    DOW JONES NEWSWIRESWatson Pharmaceuticals Inc. (WPI) might announce a deal to buy Actavis for around $6 billion on Wednesday, the Reuters news agency said Monday on ...

  3. Watson Pharmaceuticals , DISH Network Among Stocks Up on High Volume Thursday

    These stocks are up on high volume today:Watson Pharmaceuticals , Inc. ( WPI ) is experiencing a price increase on above-average volume today. 4.7 million shares hav...

  4. Watson Gains On Actavis Takeover Talk

    Watson Pharmaceuticals shares gained 5% in early action Thursday on continued speculation that it was planning to make a bid for European generic drug maker Actavis....

  5. Drug Maker Watson To Buy Actavis For About EUR4.5 Billion - Source

    U.S. generic drug maker Watson Pharmaceuticals Inc. (WPI) is close to buying rival Actavis valuing the Swiss-based company at about EUR4.5 billion, a person familiar...

  6. Green Mountain Among Stocks Up on High Volume

    These are the stocks that are up on above-average volume today:Green Mountain Coffee Roasters Inc. ( GMCR ) is up on high volume today, trading with volume of 12.1 m...

  7. Watson Pharma Seeks FDA Approval of Generic Version Of Bystolic

    DOW JONES NEWSWIRESWatson Pharmaceuticals Inc. (WPI) has filed an abbreviated new-drug application with the U.S. food and Drug Administration for its generic version...

  8. Columbia Labs Slides On FDA Setback

    Columbia Laboratories shares slid 8% Monday on news that the U.S. Food and Drug Administration has rejected its progesterone therapy over concerns about its effectiv...

  9. Watson Pharma Gains On Higher Profit Target

    Watson Pharmaceuticals shares rose 4% to $60.09 Tuesday morning, advancing after the generic drug maker raised its 2012 profit outlook. Shares were among the biggest...

  10. Watson Pharma 4Q Profit Surges On Generic Lipitor, Concerta

    Watson Pharmaceuticals Inc.'s (WPI) fourth-quarter profit surged as the introduction of a generic version of Pfizer Inc.'s (PFE) cholesterol drug Lipitor and other p...

  11. Watson Profit Rises, Firm Tweaks Outlook

    NEW YORK ( Watson Pharmaceuticals Inc. said on Tuesday that its fourth-quarter profit rose to $94.8 million, or 75 cents a share, from $18.3 million, or 15 cents a s...

  12. Patent Losses Hit Pfizer, Lilly As Both Await Alzheimer's Drug Data

    Drug makers Pfizer Inc. (PFE) and Eli Lilly & Co. (LLY) fell off the so-called "patent cliff," each reporting declines in fourth-quarter profits due to new generic c...

  1. Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales

    Pfizer Inc.'s (PFE) first-quarter profit declined 19% as sales of its top product, the cholesterol-lowering drug Lipitor, tumbled 71% in the U.S. due to competition ...

  2. UPDATE: Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales

    ("UPDATE: Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales," published at 9:01 a.m. EDT, incorrectly stated sales for Prevnar 13 in the eleventh paragraph. A c...

  3. Watson Pharma Profit Rises 21%

    Watson Pharmaceuticals said Monday its first-quarter profit increased to $54.8 million, or 43 cents a share, from $45.3 million, or 36 cents a share, in the year-ago...

  4. Pharma M&A Surge Spurred By Necessity And Opportunity

    The sudden willingness of European drug companies to launch hostile takeover bids -- underscored by numerous bids this month -- underlines the depth of the sector's ...

  5. Pending Home Sales Hit a Nearly 2-Year High in March

    FBN's Shibani Joshi breaks down afternoon market news.

  6. Equinix, Watson Pharmaceuticals Among Stocks Hitting 52-Week Highs Thursday

    These stocks set one-year highs:While trading on above-average volume, Equinix (NASDAQ:EQIX) climbed today, reaching and then surpassing its previous 52-week high of...

  7. Equinix, Watson Pharmaceuticals Among Stocks Up on High Volume Thursday

    Here are stocks that are up on high volume:Today, Equinix (NASDAQ:EQIX) is up on high volume, trading at a volume of 3.1 million, or 3.7 times its average daily volu...

‹ Prev12Next ›
Freebase CC-BY
Source: Watson Pharmaceuticals on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL